Tina Monlezun
Nurse Practitioner · Lake Arthur, LANPI 1104800846
Payments from drug & device makers
Across 86 payments — averaging $18.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$297
- Supernus Pharmaceuticals, Inc.$198
- Abbott$192
- AstraZeneca$173
- Astellas Pharma US Inc$163
- Lilly USA, LLC$115
- plus $493 from 14 others
What the payments were for
- Food & beverage$1,55195%
- Education$805%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $297 |
| Supernus Pharmaceuticals, Inc. | 12 | $198 |
| Abbott | 11 | $192 |
| AstraZeneca | 10 | $173 |
| Astellas Pharma US Inc | 6 | $163 |
| Lilly USA, LLC | 5 | $115 |
| Pfizer | 5 | $74 |
| Idorsia Pharmaceuticals US Inc | 1 | $73 |
| Bayer | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Lundbeck LLC | 2 | $37 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Exact Sciences | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Novo Nordisk | 2 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $27 |
| Novartis | 2 | $26 |
| GSK | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
| Amgen | 1 | $13 |
How this compares
$1,631 in reported general payments places this provider in the 75th percentile of 969 nurse practitioner providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 109 | $126,372 |
| MounjaroTirzepatide | 65 | $72,217 |
| TrulicityDulaglutide | 62 | $59,574 |
| JardianceEmpagliflozin | 57 | $57,804 |
| FarxigaDapagliflozin Propanediol | 46 | $47,333 |
| XareltoRivaroxaban | 27 | $32,188 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 44 | $29,674 |
| LinzessLinaclotide | 34 | $27,859 |
| EliquisApixaban | 21 | $27,084 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 30 | $22,218 |
| Xigduo XrDapaglifloz Propaned/Metformin | 23 | $21,687 |
| VascepaIcosapent Ethyl | 41 | $21,412 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $18,316 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 12 | $13,565 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $9,638 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $115 | $131,791127 claims |
| Novo NordiskOzempic | $27 | $126,372109 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $173 | $77,00790 claims |
| AbbVieLinzess, Synthroid | $297 | $32,09389 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $21 | $27,95439 claims |
| PfizerEliquis | $74 | $27,08421 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 969 nurse practitioner providers in Louisiana.
Other nurse practitioner in Lake Arthur
- Karen DeshotelLafayette$264K
- Christopher ManuelKaplan$145K
- Tammy BennettShreveport$99K
- Jessica BordelonHammond$78K
- Teri DugganBossier City$67K
- Matt LandryLafayette$50K
- Cynthia CobbLafayette$48K
- Ellen GentileWest Monroe$31K
- Reghan LittlepageAlexandria$24K
- April WoodrowOpelousas$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.